MedTrace Logo

Shivering Control After Percutaneous Nephrolithotomy

NCT04695613 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-06-01

No results posted yet for this study

Summary

Aim of the study is comparing the effect of amino acid versus magnesium sulfate infusion on postoperative shivering in patients undergoing elective percutaneous nephrolithotomy surgery under general anesthesia.

Conditions

  • Shivering Control

Interventions

DRUG

Aminoacid

amino acid infusion 150 ml/kg/hr starting preoperative

DRUG

Magnesium sulfate

magnesium sulphate bolus and infusion 60 mg/kg starting preoperative

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-03
Primary Completion
2021-03-25
Completion
2021-04-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04695613 on ClinicalTrials.gov